Paramount Bed Holdings Co., Ltd. (PBHDF)
ValueMarkers Composite Index
76% above intrinsic value ($1)
Paramount Bed Holdings Co., Ltd. (PBHDF) — VMCI valuation read
Paramount Bed Holdings Co., Ltd. (PBHDF) carries a VMCI composite of 68/100, 18 points above the Healthcare sector median of 50. Among mid-cap names, that gap places PBHDF in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).
The PBHDF insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.
**Investor frame.** Value reads PBHDF trades at 24.0x earnings, 33% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of -1.8x leaves covenant headroom, the line to track on Paramount Bed Holdings Co., Ltd.'s next 10-Q.
PBHDF rose 3.9% over the trailing 7 days, with a -21.0% read on a 30-day basis.
Paramount Bed Holdings Co., Ltd. manufactures and sells hospital and nursing care beds worldwide. The company offers mattresses and equipment for medical treatment and nursing care environments; and home care products. It also engages in the inspection and maintenance of Paramount bed products; and leasing and wholesale of welfare care products. The company was founded in 1947 and is headquartered in Tokyo, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.